Live Breaking News & Updates on Philip Duong

Stay updated with breaking news from Philip duong. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Karolinska Development's Annual General Meeting 2024

STOCKHOLM, SWEDEN – May 16, 2024. Karolinska Development AB (publ) (“Karolinska Development” or the “Company”) held the Annual General Meeting on May 16, 2024. The shareholders have had the right to exercise their voting rights in advance through postal voting pursuant to item 13 in the articles of association. Therefore, shareholders have had the choice to exercise their voting rights at the AGM by attending in person, by postal voting or through a proxy. The following resolutions were passed b ....

Philip Duong , Karolinska Institutet , Johan Dighed , Theresa Tse , Ernst Young Aktiebolag , Viktor Drvota , Hans Wigzell , Anna Lefevre Skj , Ben Toogood , Nomination Committee , Karolinska Development Ab Nasdaq Stockholm , Karolinska Development , Swedish Companies , Appropriation Of The Company , Annual General Meeting , Young Aktiebolag , Oskar Wall , Euroclear Sweden , Annual General , Swedish Corporate Governance Code , Director Remuneration Report , Nasdaq Stockholm , General Counsel ,

Interim Report - January-June 2023

STOCKHOLM – 25 August 2023. Karolinska Development AB today publishes its Interim Report - January-June 2023. The full report is available on the Company s website. “Our portfolio companies. ....

Comunidad Autonoma De Cataluna , Karolinska Institutet , Ben Toogood , Theresa Tse , Philip Duong , Viktor Drvota , Anna Lefevre Skj , Karolinska Development , World Parkinson Congress , Reportfor Karolinska Development , International Liver Congress , Karolinska Development Ab Nasdaq Stockholm , European Hematology Association , Nasdaq Stockholm , Interim Report January June , Umecrine Cognition , Modus Therapeutics , Annual General Meeting , Cochlovius Chairman ,

INVENTIVA: Inventiva announces that its partner Sino Biopharm received IND approval from the NMPA to initiate clinical trial with lanifibranor in China

Chia Tai Tianqing Pharmaceutical Group Co., Ltd., a Sino Biopharm's subsidiary, receives IND approval from the NMPA to initiate the clinical development in mainland China of lanifibranor in NASHSino Biopharm ....

United States , New York , United Kingdom , Pascaline Clerc , Gewinn Nur , Sino Biopharm , Aude Lepreux , Philip Duong , Dtx Pharma , Patricial Bank , Head Of Overseas Bd Alliance , Brunswick Group , Chinese National Medical Products Administration , Chia Tai Tianqing Pharmaceutical Group Co Ltd , Global External Affairs , Exchange Commission On , Long Island City , Hong Kong , Euronext Paris , Investigational New Drug , New Drug Application , Nasdaq Global Market , Breakthrough Therapy , Fast Track , Global External , Roquet Montegon ,

Inventiva announces that its partner Sino Biopharm received IND approval from the NMPA to initiate clinical trial with lanifibranor in China

Chia Tai Tianqing Pharmaceutical Group Co., Ltd., a Sino Biopharm’s subsidiary, receives IND approval from the NMPA to initiate the clinical development in mainland China of lanifibranor in. | May 25, 2023 ....

United States , United Kingdom , New York , Sino Biopharm , Philip Duong , Dtx Pharma , Chinese National Medical Products Administration , Head Of Overseas Bd Alliance , Chia Tai Tianqing Pharmaceutical Group Co Ltd , Long Island City , Hong Kong , Euronext Paris , Investigational New Drug , New Drug Application , Nasdaq Global Market , Breakthrough Therapy , Fast Track , Private Securities Litigation Reform Act , Inventiva Stock Exchange , Press Release , Anifibranor Iva Fr0013233012 ,